PM Modi chairs key meet of task force on COVID-19 vaccine development
New Delhi/IBNS: Prime Minister Narendra Modi took a detailed review of the current status of India’s efforts in vaccine development, drug discovery, diagnosis and testing.
Over 30 Indian vaccines are in different stages of corona vaccine development, with a few going on to the trial stages.
"In drug development three approaches are being taken. First, the repurposing of existing drugs. At least four drugs are undergoing synthesis and examination in this category.
Secondly, the development of new candidate drugs and molecules are being driven by linking high performance computational approached with laboratory verification. Thirdly, plant extracts and products are being examined for general anti-viral properties," an official government statement claimed.
In diagnosis and testing, several academic research institutions and start-ups have developed new tests, both for the RT-PCR approach and for antibody detection.
In addition, by linking laboratories all over the country, capacity for both these kinds of tests have been enormously scaled up. The problem of importing reagents for testing has been addressed by consortia of Indian start-ups and industry, meeting current requirements.
The current thrust also holds promise for the development of a robust long-term industry in this area.
The review by the PM took note of the coming together of academia, industry and government, combined with the speedy but efficient regulatory process.
PM Modi desired that such coordination and speed should be embedded into a standard operating procedure. He emphasized that what is possible in a crisis should be a part of our routine way of scientific functioning.
Appreciating the scientific coming together of computer science, chemistry and biotechnology in drug discovery, the PM suggested that a hackathon be held on this subject, linking computer science to synthesis and testing in the laboratory. The successful candidates from the hackathon could be taken up by the start-ups for further development and scaling up.
The PM added that the innovative and original manner in which Indian scientists, from basic to applied sciences, have come together with industry is heartening.
"This kind of pride, originality and sense of purpose should dominate our approach going ahead. It is only then that we can be amongst the best in the world and not followers, in science," he said.
India presently has 46,476 COVID-19 positive cases including 1571 deaths.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
